SHAILY Shaily Engineering Plastics Q4 FY25 results (Jan–Mar 2025) and concall
Shaily Engineering Plastics delivered a strong Q4 and FY25, showcasing significant revenue growth and margin expansion, largely propelled by its high-growth Healthcare segment. The company is committing INR150 crores towards capacity expansion for pen manufacturing, aiming to add 40-50 million pens annually. While confident in overall growth, management adopted a cautious stance on providing specific forward-looking numerical guidance for individual segments or total revenue, emphasizing execution based on committed volumes.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 |
|---|---|---|---|
| Revenue | 180 | 186 | 203 |
| EBITDA | 31 | 38 | 48 |
| Net profit | 13 | 18 | 30 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
